The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
The emergence of the Coronavirus Disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has led to an unprecedented pandemic, which demands urgent development of antiviral drugs and antibodies; as well as prophylactic approaches, namely vaccines. Algae biotechnology has much to offer in this scenario given the diversity of such organisms, which are a valuable source of antiviral and anti-inflammatory compounds that can also be used to produce vaccines and antibodies. Antivirals with possible activity against SARS-CoV-2 are summarized, based on previously reported activity against Coronaviruses or other enveloped or respiratory viruses. Moreover, the potential of algae-derived anti-inflammatory compounds to treat severe cases of COVID-19 is contemplated. The scenario of producing biopharmaceuticals in recombinant algae is presented and the cases of algae-made vaccines targeting viral diseases is highlighted as valuable references for the development of anti-SARS-CoV-2 vaccines. Successful cases in the production of functional antibodies are described. Perspectives on how specific algae species and genetic engineering techniques can be applied for the production of anti-viral compounds antibodies and vaccines against SARS-CoV-2 are provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Biodiesel from microalgae beats bioethanol
Chisti, Y. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2007.12.002 · Cited by 2,128
High-value products from microalgae—their development and commercialisation
Borowitzka, M. A. (2013) · Journal of Applied Phycology · doi:10.1007/s10811-013-9983-9 · Cited by 1,585
Liang, Y., Sarkany, N., & Cui, Y. (2009) · Biotechnology Letters · doi:10.1007/s10529-009-9975-7 · Cited by 1,059
Chemical structures and bioactivities of sulfated polysaccharides from marine algae
Jiao, G., Yu, G., Zhang, J., & Ewart, H. S. (2011) · Marine Drugs · doi:10.3390/md9020196 · Cited by 1,054
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Jiang, S., Hillyer, C., & Du, L. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.03.007 · Cited by 847
Peng, J., Yuan, J.-P., Wu, C.-F., & Wang, J.-H. (2011) · Marine Drugs · doi:10.3390/md9101806 · Cited by 820
Microalgae as versatile cellular factories for valued products
Koller, M., Muhr, A., & Braunegg, G. (2014) · Algal Research · doi:10.1016/j.algal.2014.09.002 · Cited by 639 · cited 1×
“salina [41] and astaxanthin extracted from H.”
Bioactivity and applications of sulphated polysaccharides from marine microalgae
Raposo, M., De Morais, R., & Bernardo de Morais, A. (2013) · Marine Drugs · doi:10.3390/md11010233 · Cited by 594
Hayashi, T., Hayashi, K., Maeda, M., & Kojima, I. (1996) · Journal of Natural Products · doi:10.1021/np960017o · Cited by 422 · cited 1×
“Calcium spirulan found in Arthrospira platensis is an inhibitor of viral replication of HSV-1, human cytomegalovirus, measles virus, mumps virus, IAV, and HIV-1; blocking the virus before penetrating host cells [151].”
BackgroundHayashi, K., Nakano, T., Hashimoto, M., Kanekiyo, K., & Hayashi, T. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2007.10.017 · Cited by 247 · cited 1×
“pinnatifida has anti-HSV activity [140] and anti-IAV activity in vitro and in mice with normal and compromised immunity [141].”
BackgroundActivity of Porphyridium sp. polysaccharide against herpes simplex viruses in vitro and in vivo
Huheihel, M., Ishanu, V., Tal, J., & Arad, S. (. (2002) · Journal of Biochemical and Biophysical Methods · doi:10.1016/s0165-022x(01)00186-5 · Cited by 217 · cited 1×
“Sulfated EPS have shown antiviral activity against the herpes simplex virus types 1 and 2 (HSV-1 and -2) in a concentration-dependent manner in infected cells without cytotoxic effects on Vero cells at concentrations up to 250 μg/mL [159].”
BackgroundSeparation and fractionation of exopolysaccharides from Porphyridium cruentum
Patel, A. K., Laroche, C., Marcati, A., Ursu, A. V., Jubeau, S., Marchal, L., Petit, E., Djelveh, G., & Michaud, P. (2013) · Bioresource Technology · doi:10.1016/j.biortech.2012.12.038 · Cited by 174
Fabregas, J., Garcı́a, D., Fernandez-Alonso, M., Rocha, A. I., Gómez-Puertas, P., Escribano, J. M., Otero, A., & Coll, J. M. (1999) · Antiviral Research · doi:10.1016/s0166-3542(99)00049-2 · Cited by 144 · cited 3×
“In addition, EPS from Porphyridium sp. have shown antiviral activity against other enveloped viruses such as the viral hemorrhagic septicemia virus (VHSV) and the African swine fever virus (ASFV) [161]; moreover, they have activity against retroviruses such as the murine leukemia virus (MuLV) and murine sarcoma virus…”
BackgroundMilking microalga Dunaliella salina for β‐carotene production in two‐phase bioreactors
Hejazi, M. A., Holwerda, E., & Wijffels, R. H. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.10914 · Cited by 128
Anti-viral activity of red microalgal polysaccharides against retroviruses
Talyshinsky, M. M., Souprun, Y. Y., & Huleihel, M. M. (2002) · Cancer Cell International · doi:10.1186/1475-2867-2-8 · Cited by 109
Current advances in the algae-made biopharmaceuticals field
Rosales-Mendoza, S., Solís-Andrade, K. I., Márquez-Escobar, V. A., González-Ortega, O., & Bañuelos-Hernandez, B. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1739643 · Cited by 55
Self-citationLotfi, H., Sheervalilou, R., & Zarghami, N. (2017) · BioImpacts · doi:10.15171/bi.2018.16 · Cited by 30
Cited by
Microalgae: therapeutic potentials and applications
Khavari, F., Saidijam, M., Taheri, M., & Nouri, F. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06422-w · Cited by 257
Sustainable Microalgae and Cyanobacteria Biotechnology
López-Hernández, J.-F., Kean-Meng, T., Asencio-Alcudia, G.-G., Asyraf-Kassim, M., Alvarez-González, C.-A., & Márquez-Rocha, F.-J. (2022) · Applied Sciences · doi:10.3390/app12146887 · Cited by 30
Ayub, A., Rahayu, F., Khamidah, A., Antarlina, S. S., Iswari, K., Supriyadi, K., Mufidah, E., Singh, A., Chopra, C., & Wani, A. K. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-06916-3 · Cited by 29
“Carrageenan, a sulfated polysaccharide sourced from microalgae, demonstrates inhibitory effects on viral attachment, transcription, and replication within host cells [166].”
Munawaroh, H. S. H., Gumilar, G. G., Pratiwi, R. N., Khoiriah, S. F., Ningrum, A., Martha, L., Chew, K. W., & Show, P.-L. (2024) · Algal Research · doi:10.1016/j.algal.2024.103468 · Cited by 9
Metadata
- Authors
- Rosales-Mendoza, S., García-Silva, I., González-Ortega, O., Sandoval-Vargas, J. M., Malla, A., & Vimolmangkang, S.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-09-04
- Volume
- 25
- Issue
- 18
- Pages
- 4049
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W3083467465
- Cited by
- 79
- References
- 19
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.